# Hikma Pharmaceuticals USA Inc. – FDA Inspection, Nov 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/e7b030d5-aa1b-472b-8874-97ba0cb35d84
Source feed: FDA_Inspections

> FDA inspection 1222115 of Hikma Pharmaceuticals USA Inc., November 03, 2023. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 211 and 314. Form 483 issued. 18 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222115
- Company Name: Hikma Pharmaceuticals USA Inc.
- Inspection Date: 2023-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Citation Count: 5

## Related Documents

- FDA Inspection 1304368 - 2026-05-13
- [FDA Inspection 1237333 - 2024-06-12](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/c508334e-3cc5-450a-a665-5fb2a067f1ed)
- FDA Inspection 1176451 - 2022-07-07
- [FDA Inspection 1106822 - 2019-09-10](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/607fb2a5-7932-4aff-a16c-1afe2023de82)
- FDA Inspection 1067645 - 2018-09-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/646ab738-7dde-4473-abdb-76058836c610
